The Life Sciences Divide: Opportunity and Risk in a Bifurcated Market
May 5, 2026. In February, a two-year-old life sciences building near Seattle’s Space Needle sold for less than 30% of its assessed value. But that same month, CBRE released its 2025 life sciences report for New York City, which noted that annual leasing velocity for 2025 exceeded 2024’s total by 138%.
Site Inspection for Securitization Readiness
April 21, 2026.
A rating agency engaged Summer Street Advisors to support the evaluation of a single-family rental portfolio ahead of a planned securitization. The portfolio included 20 properties spread across three states, each with varying conditions and local market dynamics.
Private Credit, Explained: Why Wall Street Is Suddenly Nervous
April 7, 2026. Private credit used to be one of finance’s quieter success stories. It lived mostly outside the glare of public markets, in funds that lent directly to companies rather than buying broadly traded bonds.
Navigating Valuation Risk in a Complex Loan Portfolio
March 17, 2026. An institutional investment manager was evaluating the acquisition of a $500 million loan pool secured by approximately 50 multifamily and mixed-use properties, originally originated by a major New York–based financial institution. To support its due diligence, Summer Street Advisors was engaged to conduct an appraisal review of the underlying collateral.
America Isn’t Overbuilt – It’s Misbuilt: Rethinking Commercial Real Estate
March 10, 2026. For years, the prevailing narrative in commercial real estate has been simple: America is overbuilt. Too many offices. Too many strip malls. Too much supply chasing too little demand.